Clinical Endpoints Well-Positioned to Transition Treatments to Future Patients

April 6, 2021 – As researchers worldwide develop new therapies for diseases such as Alzheimer’s, Donnell Carmichael, VP for Clinical Research Operations, says Clinical Endpoints is well-positioned to help transition these treatments to future patients.

“Clinical Endpoints is introducing physicians to clinical research to give their patients access to new and innovative healthcare technologies. This can provide new hope to patients seeking alternative care.”

Learn more about Clinical Endpoints at https://clinicalendpoints.com/.